drugset / Trial / NCT04436081

Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease

NCT04436081

RandomizedCrossoverQuadruple-blindTreatment

Summary

This is a randomized, double-blinded, placebo-controlled, crossover trial that aims to 1) determine the efficacy of THC-free cannabidiol (CBD oil) in reducing the severity of agitation among participants and 2) determine whether THC-free CBD oil can reduce the burden on caregivers and increase the participants' quality of life.

Timeline

Start
2021-02-26
Primary completion
2024-03
Completion
2024-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cannabidiol Other / unclassified 45 mg Oral

Indications